Eczema and ceramides: An update

Contact Dermatitis

Volumn 69, Issue 2, 2013, Pages 65-71

  Jungersted, Jakob Mutanu ^a,b   Agner, Tove ^b  

^a ROSKILDE HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

ceramides; eczema; occlusion and genetics; treatment

Indexed keywords

CALCINEURIN INHIBITOR; CERAMIDE; CERAMIDE DERIVATIVE; CORTICOSTEROID DERIVATIVE; DERMATOLOGICAL AGENT; DODECYL SULFATE SODIUM; FILAGGRIN; MOISTURIZING AGENT; TOPICAL AGENT; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; CHEMICAL INJURY; ECZEMA; GAUCHER DISEASE; GENETIC ASSOCIATION; HUMAN; HYPOHIDROTIC ECTODERMAL DYSPLASIA; ICHTHYOSIS; LIPOGENESIS; LOSS OF FUNCTION MUTATION; NIEMANN PICK DISEASE; PH; REVIEW; SJOEGREN LARSSON SYNDROME; SKIN IRRITATION; SKIN SURFACE; SYSTEMIC THERAPY; TOPICAL TREATMENT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

CERAMIDES; ECZEMA; OCCLUSION AND GENETICS; TREATMENT;

CERAMIDES; DERMATITIS, ATOPIC; EPIDERMIS; HUMANS;

EID: 84880580973     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/cod.12073     Document Type: Review

References (79)

1. Michaels A S, Chandrasekaran S K, Shaw J E,. Drug permeation through human skin: theory and in vitro experimental measurements. AIChE 1975: 21: 985-996.
2. Elias P M,. Epidermal lipids, barrier function and desquamation. J Invest Dermatol 1983: 80: S44-S49.
3. Van Smeden J, Hoppel L, van der Heijden R, et al. LC-MS analysis of stratum corneum lipids: ceramide profiling and discovery. J Invest Dermatol 2011: 52: 1211-1221.
4. Iwai I, Han H, Hollander L, et al. The human skin barrier is organized as stacked bilayers of fully extended ceramides with cholesterol molecules associated with the ceramide sphingoid moiety. J Invest Dermatol 2012: 143: 345-359.
5. Elias P M, Menon G K,. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991: 24: 1-26.
6. Proksch E, Brandner J M, Jensen J M,. The skin: an indispensable barrier. Exp Dermatol 2008: 17: 1063-1072.
7. Jungersted J M, Hellgren L I, Jemec G B E, Agner T,. Lipids and skin barrier function-a clinical perspective. Contact Dermatitis 2008: 58: 255-262.
8. Rogers J, Harding C, Mayo A, Banks J, Rawlings A,. Stratum corneum lipids: the effect of aging and the seasons. Arch Dermatol Res 1996: 228: 765-770.
9. Bouwstra J A, Gorris G S, Dubbelaar F E R, Weerheim A M, Ijzerman A P,. Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res 1998: 39: 186-196.
10. Velkova V, Lafleur M,. Influence of the lipid composition on the organization of skin lipid model mixtures: an infrared spectroscopy investigation. Chem Phys Lipids 2002: 117: 63-74.
11. Masukawa Y, Narita H, Sato H, et al. Comprehensive quantification of ceramide species in human stratum corneum. J Lipid Res 2009: 50: 1708-1719.
12. Hinder A, Schmelzer C E H, Rawlings A V, Neubert R H H,. Investigation of the molecular structure of the human stratum corneum ceramides [NP] and [EOS] by mass spectrometry. Skin Pharmacol Physiol 2011: 24: 127-135.
13. Joo K M, Nam G W, Park S Y, et al. Relationship between cutaneous barrier function and ceramide species in human stratum corneum. J Dermatol Sci 2010: 60: 47-50.
14. Novotný J, Janusová B, Novotný M, Hrabálek A, Vávrová K,. Short-chain ceramide decrease skin barrier properties. Skin Pharmacol Physiol 2009: 22: 22-30.
15. Palmer C A N, Irvine A D, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006: 38: 441-446.
16. Imokawa G, Akihito A, Jin K, Higaki Y, Kawashima M, Hidano A,. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991: 96: 523-526.
17. Yamamoto A, Serizawa S, Ito M, Sato Y,. Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res 1991: 283: 219-223.
18. Di Nardo A, Wertz P, Giannetti A, Seidenari S,. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998: 78: 27-30.
19. Bleck O, Abeck D, Ring J, Hoppe U, Vietzke J P, Wolber R, Brandt O, Schreiner V,. Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids on non-lesional skin of atopic eczema. J Invest Dermatol 1999: 113: 894-900.
20. Matsumoto M, Umemoto N, Sugiura H, Uehara M,. Difference in ceramide composition between 'dry' and 'normal' skin in patients with atopic dermatitis. Acta Derm Venereol 1998: 79: 246-247.
21. Imokawa G,. A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of spingomyelin and glucosylceramide. J Dermatol Sci 2009: 55: 1-9.
22. Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G,. The skin and atopic dermatitis patients contains a novel enzyme, glucosylceramide spingomyelin deaculase, which cleaves the N-acyl linkage of spingomyelin and glucosylceramide. Biochem J 2000: 350: 747-756.
23. Redoules D, Tarroux R, Périé J,. Epidermal enzymes: their role in homeostasis and their relationships with dermatoses. Skin Pharmacol Appl Skin Physiol 1998: 11: 183-192.
24. Cork M J, Danby S G, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009: 129: 1892-1908.
25. Jungersted J M, Scheer H, Mempel M, et al. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy 2010: 65: 911-918.
26. Angelova-Fischer I, Mannheimer A C, Hinder A, et al. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling. Exp Dermatol 2011: 20: 351-356.
27. Janssen M, Smeden J S, Gooris G S, et al. Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema. J Invest Dermatol 2011: 131: 2136-2138.
28. Cho H J, Chung B Y, Lee H B, et al. Quantitative study of stratum corneum ceramides contents in patients with sensitive skin. J Dermatol 2012: 39: 295-300.
29. Jungersted J M, Høgh J K, Hellgren L I, et al. Ceramide profile in hypohidrotic ectodermal dysplasia. Clin Exp Dermatol 2012: 37: 153-155.
30. Nakajima K, Uchida Y, Akiyama M, et al. Altered lipid profile in the stratum corneum of Sjögren-Larsson syndrome. J Dermatol Sci 2011: 63: 64-66.
31. Sidransky E, Fartasch M, Lee R E, et al. Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease. Pediatr Res 1996: 39: 134-141.
32. Milner M E, O'Guin W M, Holbrook K A, Dale B A,. Abnormal lamellar granules in harlequin ichthyosis. J Invest Dermatol 1992: 99: 824-829.
33. Schmuth M, Man M Q, Weber F, et al. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol 2000: 115: 459-466.
34. Jiang Y J, Uchida Y, Lu B, et al. Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor o in human keratinocytes. J Biol Chem 2009: 284: 18942-18952.
35. Ramsing D W, Agner T,. Preventive and therapeutic effects of a moisturizer. An experimental study of human skin. Acta Derm Venereol 1997: 77: 335-337.
36. Lodén M,. The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol 2005: 19: 672-688.
37. Held E, Sveinsdõttir S, Agner T,. Effect of long-term use of moisturizer on skin hydration. Acta Derm Venereol 1999: 79: 49-51.
38. Held E, Agner T,. Effect of moisturizers on skin susceptibility to irritants. Acta Derm Venereol 2001: 81: 104-107.
39. 2. Acta Derm Venereol 2003: 83: 93-97.
40. Caussin J, Gooris G S, Groenink H W W, Wiechers J W, Bouwstra J A,. Interaction of lipophilic moisturizers on stratum corneum lipid domains in vitro and in vivo. Skin Pharmacol Physiol 2007: 20: 175-186.
41. Miller D W, Koch S B, Yentzer B A, et al. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol 2011: 10: 531-537.
42. Buraczewska I, Berne B, Lindberg M, Lodén M, Törmä H,. Moisturizers change the mRNA expression of enzymes synthesizing skin barrier lipids. Arch Dermatol Res 2009: 3001: 587-594.
43. Buraczewska I, Berne B, Lindberg M, Lodén M, Törmä H,. Long-term treatment with moisturisers affects the mRNA levels of genes involved in keratinocyte differentiation and desquamation. Arch Dermatol Res 2009: 301: 175-181.
44. Lodén M,. Effect of moisturizers on epidermal barrier function. Clin Dermatol 2012: 30: 286-296.
45. Lucky A W, Leach A D, Laskarzewski P, Wenck H,. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997: 14: 321-324.
46. Kao J S, Fluhr J W, Man M Q, et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003: 120: 456-464.
47. Sheu H M, Lee J Y, Chai C Y, Kuo K W,. Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids. Br J Dermatol 1997: 136: 884-890.
48. Hong S P, Oh Y, Jung M, Lee S, Jeon H, Cho M Y, Lee S H, Choi E H,. Topical calcitriol restores the impairment of the epidermal permeability and antimicrobial barriers induced by corticosteroids. Br J Dermatol 2010: 162: 1251-1260.
49. Jensen J M, Pfeiffer S, Witt M, et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 2009: 123: 1124-1133.
50. Jensen J M, Scherer A, Wanke C, et al. Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis. Allergy 2012: 67: 413-423.
51. Jungersted J M, Høgh J K, Hellgren L I, Jemec G B E, Agner T,. Effect of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin. Acta Derm Venereol 2011: 91: 290-294.
52. Paslin D, Wertz P,. A study to determine the effect of tacrolimus on ceramide levels in stratum corneum of patients with atopic dermatitis. Int J Dermatol 2006: 45: 352-356.
53. Jungersted J M, Høgh J K, Hellgren L I, Jemec G B E, Agner T,. Changes in skin barrier during treatment with systemic alitretinoin: focus on skin susceptibility and stratum corneum ceramides. Arch Dermatol Res 2010: 302: 653-656.
54. Grether-Beck S, Salahshour-Fard M, Timmer A, et al. Ceramide and raft signalling are linked with each other in UVA radiation-induced gene expression. Oncogene 2008: 27: 4768-4778.
55. Lehmann P, Hölzle E, Melnik B, Plewig G,. Effects of ultraviolet A and B on the skin barrier: a function, electron microscopic and lipid biochemical study. Photodermatol Photoimmunol Photomed 1991: 8: 129-134.
56. Jungersted J M, Høgh J K, Hellgren L I, et al. The impact of ultraviolet therapy on stratum corneum ceramides and barrier function. Photodermatol Photoimmunol Photomed 2011: 27: 331-333.
57. Frosch P J, Wissing C,. Cutaneous sensitivity to ultraviolet light and chemical irritants. Arch Dermatol Res 1982: 272: 269-278.
58. Agner T, Serup J,. Skin reactions to irritants assessed by non-invasive, bioengineering methods. Contact Dermatitis 1989: 20: 352-359.
59. Clemmensen A, Andersen K E, Clemmensen O, Tan Q, Petersen T K, Kruse T A, Thomassen M,. Genome-wide expression analysis of human in vivo irritated epidermis: differential profiles induced by sodium lauryl sulphate and nonanoic acid. J Invest Dermatol 2010: 130: 2201-2210.
60. Pedersen L K, Held E, Johansen J D, Agner T,. Short-term effects of alcohol-based disinfectant and detergent on skin irritation. Contact Dermatitis 2005: 52: 82-87.
61. Pedersen L K, Held E, Johansen J D, Agner T,. Less skin irritation from alcohol-based disinfection than from detergent used for hand disinfection. Br J Dermatol 2005: 153: 1142-1146.
62. Löffler H, Kampf G, Schmermund D, Maibach H I,. How irritant is alcohol? Br J Dermatol 2007: 157: 74-81.
63. Fartasch M,. Ultrastructure of the epidermal barrier after irritation. Microsc Res Tech 1997: 37: 193-199.
64. Ramsing D W, Agner T,. Effect of glove occlusion on human skin (I). Short-term experimental exposure. Contact Dermatitis 1996: 34: 1-5.
65. Ramsing D W, Agner T,. Effect of glove occlusion on human skin (II). Long-term experimental exposure. Contact Dermatitis 1996: 34: 258-262.
66. Graves C J, Edwards C, Marks R,. The effect of protective occlusive gloves on stratum corneum barrier properties. Contact Dermatitis 1995: 33: 183-187.
67. Mennen U, Wiese A,. Fingertip injuries management with semiocclusive dressing. J Hand Surg 1993: 18: 416-422.
68. Agren M S, Karlsmark T, Hansen J B, Rygaard J,. Occlusion versus air exposure on full-thickness biopsy wounds. J Wound Care 2001: 10: 301-304.
69. Rippke F, Schreiner V, Schwanitz H J,. The acidic milieu of the horny layer-new findings on the physiology and pathophysiology of skin pH. Am J Clin Dermatol 2002: 3: 261-272.
70. Kannon G A, Garrett A B,. Moist wound healing with occlusive dressings. A clinical review. Dermatol Surg 1995: 21: 583-590.
71. Aly R, Shirley C, Cunico B, Maibach H I,. Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J Invest Dermatol 1978: 71: 378-381.
72. Wetzky U, Bock M, Wulfhorst B, John S M,. Short- and long-term effect of single and repetitive glove occlusion on the epidermal barrier. Arch Dermatol Res 2009: 301: 595-602.
73. Jungersted J M, Høgh J K, Hellgren L I, Jemec G B E, Agner T,. Skin barrier response to occlusion of healthy and irritated skin. Differences in TEWL, erythema and stratum corneum lipids. Contact Dermatitis 2010: 63: 313-319.
74. Chen H, Common J E, Haines R L, et al. Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations. Br J Dermatol 2011: 165: 106-114.
75. Odhiambo J A, Williams H C, Clayton T O, et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009: 124: 1251-1258.
76. Gunathilake R, Schurer N Y, Shoo B A, et al. pH-regulated mechanisms account for pigment-type differences in epidermal barrier function. J Invest Dermatol 2009: 129: 1719-1729.
77. Berardesca E, Pirot F, Singh M, Maibach H,. Differences in stratum corneum pH gradient when comparing white Caucasians and black African-American skin. Br J Dermatol 1998: 139: 855-857.
78. Fotoh C, Elkhyat A, Mac S, et al. Cutaneous differences between Black, African or Caribbean Mixed-race and Caucasian women: biometrological approach of the hydrolipidic film. Skin Res Technol 2008: 14: 327-335.
79. Jungersted J M, Høgh J K, Hellgren L I, et al. Ethnicity and stratum corneum ceramides. Br J Dermatol 2010: 163: 1169-1173.